|
|
||||||||
Clinical Chemistry, Vol 40, 407-410, Copyright © 1994 by American Association for Clinical Chemistry
J Mora-Brugues, N Gascon-Roche, J Rodriguez-Espinosa, M Cortes-Rius and F Gonzalez-Sastre
Servei de Bioquimica, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
We evaluated the technical performance of the Ciba Corning ACS:180 automated immunoassay system for the following analytes: thyroid- stimulating hormone, free thyroxine, luteinizing hormone, follicle- stimulating hormone, prolactin, human chorionic gonadotropin, carcino- embryonic antigen, and prostate-specific antigen. The characteristics evaluated were: precision, carryover, linearity, lower limit of detection, analytical interferences, and comparison with other methods. Satisfactory results were obtained in the within-run and between-run precision studies. Neither sample nor reagent carryover was found for any assay. The range of linearity was acceptable. For some of the assays evaluated, the lower limit of detection was better than that claimed by the manufacturer. Correlation between ACS:180 methods and compared methods was adequate. We conclude that the ACS:180 offers good reliability, practicability, and performance capabilities.
The following articles in journals at HighWire Press have cited this article:
![]() |
H. A. Hendriks, W. Kortlandt, and W. M. Verweij Standardized Comparison of Processing Capacity and Efficiency of Five New-Generation Immunoassay Analyzers Clin. Chem., January 1, 2000; 46(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |